Variant report
Variant | esv3337129 |
---|---|
Chromosome Location | chr2:50836948-50838996 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs570145877 | chr2:50836953-50836954 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs537171194 | chr2:50836981-50836982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs367707922 | chr2:50837039-50837040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs371401643 | chr2:50837053-50837054 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs552284695 | chr2:50837059-50837060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs181412840 | chr2:50837080-50837081 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs138508725 | chr2:50837114-50837115 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs186224467 | chr2:50837155-50837156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs57185802 | chr2:50837191-50837192 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs190730751 | chr2:50837192-50837193 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs535373879 | chr2:50837247-50837248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs149243328 | chr2:50837262-50837263 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575083285 | chr2:50837302-50837303 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs112535080 | chr2:50837340-50837341 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375780958 | chr2:50837364-50837365 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs565061415 | chr2:50837398-50837399 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs534935843 | chr2:50837407-50837408 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs370142142 | chr2:50837432-50837433 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs374957530 | chr2:50837469-50837470 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1469157 | chr2:50837494-50837495 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
21 | rs530472102 | chr2:50837509-50837510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs542137130 | chr2:50837540-50837541 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs1469158 | chr2:50837549-50837550 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs375207970 | chr2:50837566-50837567 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs77307153 | chr2:50837579-50837580 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs555908817 | chr2:50837614-50837615 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs183139318 | chr2:50837616-50837617 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs1469159 | chr2:50837708-50837709 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs372248659 | chr2:50837765-50837766 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371867677 | chr2:50837780-50837781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs201213746 | chr2:50837781-50837782 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs200856936 | chr2:50837800-50837801 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs70948722 | chr2:50837816-50837817 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs5831144 | chr2:50837892-50837893 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34423309 | chr2:50837893-50837894 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs546612662 | chr2:50837894-50837895 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs28635808 | chr2:50837916-50837917 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs113435471 | chr2:50837921-50837922 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs12997910 | chr2:50837940-50837941 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186037096 | chr2:50837957-50837958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs535779217 | chr2:50837988-50837989 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs556992489 | chr2:50837993-50837994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs144520567 | chr2:50837996-50837997 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs545134740 | chr2:50838012-50838013 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs558726463 | chr2:50838033-50838034 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375279607 | chr2:50838039-50838040 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs368628635 | chr2:50838081-50838082 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs372620039 | chr2:50838088-50838089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs148424012 | chr2:50838139-50838140 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs369298649 | chr2:50838149-50838150 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Cognitive impairment | 21505072 | CNVD |
Psychiatric disorder | 19734545 | CNVD |
Autism | 20844286 | CNVD |
Schizophrenia | 20838587 | CNVD |
Schizophrenia | 20718829 | CNVD |
Autism | 19218893 | CNVD |
Autism | 22209245 | CNVD |
Neuropsychiatric disorder | 21827697 | CNVD |
Schizophrenia | 22118685 | CNVD |
Autism | 20663923 | CNVD |
Schizophrenia | 21285140 | CNVD |
Breast cancer | 22522925 | CNVD |
Breast cancer | 21990379 | CNVD |
Schizophrenia | 22885689 | CNVD |
Autism | 20964600 | CNVD |
Schizophrenia | 19521646 | CNVD |
Attention deficit hyperactivity disorder | 22214315 | CNVD |
Chronic motor tic disorder | 22214315 | CNVD |
Schizophrenia | 22214315 | CNVD |
Mental retardation | 19896112 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:50832800-50838400 | Weak transcription | Fetal Brain Female | brain |
2 | chr2:50834200-50838200 | Weak transcription | Hela-S3 | cervix |
3 | chr2:50834200-50838600 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
4 | chr2:50834600-50838800 | Weak transcription | HUES48 Cell Line | embryonic stem cell |
5 | chr2:50835200-50847200 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
6 | chr2:50835200-50848600 | Weak transcription | Brain Germinal Matrix | brain |
7 | chr2:50835400-50838400 | Weak transcription | Fetal Muscle Leg | muscle |
8 | chr2:50838200-50841400 | Enhancers | Hela-S3 | cervix |
9 | chr2:50838400-50838800 | Enhancers | Fetal Brain Female | brain |
10 | chr2:50838400-50838800 | Enhancers | Fetal Muscle Leg | muscle |
11 | chr2:50838400-50840200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr2:50838600-50839000 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
13 | chr2:50838600-50840000 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr2:50838800-50839000 | Enhancers | Brain Dorsolateral Prefrontal Cortex | brain |
15 | chr2:50838800-50839400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
16 | chr2:50838800-50849400 | Weak transcription | Fetal Brain Female | brain |